NRIX

NASDAQStock

Nurix Therapeutics, Inc.

$15.03-0.58 (-3.72%)

52-Week Range

$8.24

$21.47

Key Stats

Market Cap

1.3B

P/E Ratio

—

Dividend Yield

—

Beta

2.02

Volume

481.1K

Avg Volume

866.6K

Performance

+0.06%

-17.89%

+84.95%

YTD

-13.57%

+12.06%

+71.54%

-65.59%

Price Chart

ETF Exposure

NRIX is held by 106 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
SLT	Pacer Salt High truBeta US Market ETF	0.00%	1,177	$23K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	1,177	$23K	$1.0M	0.79%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	161	$4K	$820.6M	0.25%
VETS	Pacer Military Times Best Employers ETF	0.00%	1,177	$23K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	1,177	$23K	$3.7M	0.70%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	27	$622	$337.7M	0.32%

PreviousPage 3 of 3

About NRIX ETF Exposure

Nurix Therapeutics, Inc. (NRIX) is held by 106 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.3B, NRIX is a widely held institutional stock. The stock currently trades at $15.03. Investors can gain exposure to NRIX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NRIX, sorted by portfolio weight.